6.
Deng M, Yan W, Gu Z, Li Y, Chen L, He B
. Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer's Disease. Molecules. 2023; 28(3).
PMC: 9920976.
DOI: 10.3390/molecules28031486.
View
7.
Farooqui M, Ikram A, Suriya S, Saleem S, Quadri S, Robinson M
. Cytokine Registry In Stroke Patients (CRISP): Protocol of a prospective observational study. Medicine (Baltimore). 2020; 99(28):e20921.
PMC: 7360230.
DOI: 10.1097/MD.0000000000020921.
View
8.
Fisar Z
. Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer's Disease and Identifying Promising Drug Targets. Biomolecules. 2022; 12(11).
PMC: 9687482.
DOI: 10.3390/biom12111676.
View
9.
Gu R, Fang T, Nelson A, Gyoneva S, Gao B, Hedde J
. Proteomic Characterization of the Dynamics of Ischemic Stroke in Mice. J Proteome Res. 2021; 20(7):3689-3700.
PMC: 8256414.
DOI: 10.1021/acs.jproteome.1c00259.
View
10.
Guo Z, Li Z, Zhang M, Bao M, He B, Zhou X
. LncRNA FAS-AS1 upregulated by its genetic variation rs6586163 promotes cell apoptosis in nasopharyngeal carcinoma through regulating mitochondria function and Fas splicing. Sci Rep. 2023; 13(1):8218.
PMC: 10203136.
DOI: 10.1038/s41598-023-35502-z.
View
11.
Hanlon M, Canavan M, Barker B, Fearon U
. Metabolites as drivers and targets in rheumatoid arthritis. Clin Exp Immunol. 2022; 208(2):167-180.
PMC: 9188347.
DOI: 10.1093/cei/uxab021.
View
12.
Hong M, Shi H, Wang N, Tan H, Wang Q, Feng Y
. Dual Effects of Chinese Herbal Medicines on Angiogenesis in Cancer and Ischemic Stroke Treatments: Role of HIF-1 Network. Front Pharmacol. 2019; 10:696.
PMC: 6606950.
DOI: 10.3389/fphar.2019.00696.
View
13.
Kim Y, Santos R, Gage F, Marchetto M
. Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges. Front Cell Neurosci. 2017; 11:30.
PMC: 5306135.
DOI: 10.3389/fncel.2017.00030.
View
14.
Kwon D, Hwang J, Kim S, Jang Y, Shin T, Lee G
. Cerebrospinal Fluid Metabolome in Parkinson's Disease and Multiple System Atrophy. Int J Mol Sci. 2022; 23(3).
PMC: 8836409.
DOI: 10.3390/ijms23031879.
View
15.
Li Y, Cui R, Fan F, Lu Y, Ai Y, Liu H
. The Efficacy and Safety of Ischemic Stroke Therapies: An Umbrella Review. Front Pharmacol. 2022; 13:924747.
PMC: 9355553.
DOI: 10.3389/fphar.2022.924747.
View
16.
Licari C, Tenori L, Giusti B, Sticchi E, Kura A, De Cario R
. Analysis of Metabolite and Lipid Association Networks Reveals Molecular Mechanisms Associated with 3-Month Mortality and Poor Functional Outcomes in Patients with Acute Ischemic Stroke after Thrombolytic Treatment with Recombinant Tissue Plasminogen.... J Proteome Res. 2021; 20(10):4758-4770.
PMC: 8491161.
DOI: 10.1021/acs.jproteome.1c00406.
View
17.
Louati K, Maalej A, Kolsi F, Kallel R, Gdoura Y, Borni M
. Differential Proteome Profiling Analysis under Pesticide Stress by the Use of a Nano-UHPLC-MS/MS Untargeted Proteomic-Based Approach on a 3D-Developed Neurospheroid Model: Identification of Protein Interactions, Prognostic Biomarkers, and Potential.... J Proteome Res. 2023; 22(11):3534-3558.
PMC: 10629271.
DOI: 10.1021/acs.jproteome.3c00395.
View
18.
Ma Y, Qu Y, Fei Z
. Vascular endothelial growth factor in cerebral ischemia. J Neurosci Res. 2011; 89(7):969-78.
DOI: 10.1002/jnr.22628.
View
19.
Alvi A, Al Kury L, Ijaz M, Shah F, Khan M, Sheikh A
. Post-Treatment of Synthetic Polyphenolic 1,3,4 Oxadiazole Compound A3, Attenuated Ischemic Stroke-Induced Neuroinflammation and Neurodegeneration. Biomolecules. 2020; 10(6).
PMC: 7355474.
DOI: 10.3390/biom10060816.
View
20.
Mollet I, Marto J, Mendonca M, Baptista M, Vieira H
. Remote but not Distant: a Review on Experimental Models and Clinical Trials in Remote Ischemic Conditioning as Potential Therapy in Ischemic Stroke. Mol Neurobiol. 2021; 59(1):294-325.
PMC: 8533672.
DOI: 10.1007/s12035-021-02585-6.
View